about
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.Atonal homolog 1 is a tumor suppressor geneMucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.Practical and molecular evaluation of colorectal cancer: new roles for the pathologist in the era of targeted therapy.A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction.Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.Assessment of the microbiota in microdissected tissues of Crohn's disease patientsOrnidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy.Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathyCrohn's disease and infections: a complex relationship.Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in RatsCoexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
P50
Q27851449-A0E9D7FD-67FB-4310-8209-5C9CF8C83DA9Q28474993-93F90629-35F9-4C57-84EE-F07F42897AA3Q30945619-05C0362E-EEF1-43E3-9694-84240642B023Q33594767-72F2BE17-1364-4DE7-9B3F-ED714868C066Q33599727-3657CE38-6212-4561-9F62-82B5DFE17918Q33766675-C95C6B75-BC23-4861-A3F0-EB69BF892B6FQ34108445-76E41EB8-A548-4432-B147-B455F54D77ECQ34410821-473B924E-DAB0-4F34-ACCA-5DDA0C3B81DCQ34610304-E95A3B79-6C3B-478F-BDD7-9FD011C6F1D6Q34612166-462A33F1-CC08-4FF4-B12F-44FC5D64EBDEQ34769969-1504AF4C-F104-4203-B5CC-E178DF97ADA7Q34784772-DD74B07B-302C-46F0-9F00-0A59290866D4Q35083186-BB74BCB4-A782-4462-8986-2D9B1A3F6D1BQ35936315-F92ED822-EA64-4067-931E-0B68013434A5Q36203396-61300F12-0694-455E-A090-237B1E6AD325Q36242886-D44A5335-8631-45E7-9F0F-D6A92B9F98E4Q36853911-7D7171A2-441D-481D-8AFF-9BC5850F4770
P50
description
onderzoeker
@nl
name
Gert De Hertogh
@ast
Gert De Hertogh
@en
Gert De Hertogh
@nl
Gert De Hertogh
@sl
type
label
Gert De Hertogh
@ast
Gert De Hertogh
@en
Gert De Hertogh
@nl
Gert De Hertogh
@sl
prefLabel
Gert De Hertogh
@ast
Gert De Hertogh
@en
Gert De Hertogh
@nl
Gert De Hertogh
@sl